Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Bradbury Daniel
Relationship:   Director
City:   San Diego
State:   CA
   
Insider Summary:
  
   
Companies Owned :   8    
Direct Shares   223,469    

Indirect Shares

   3,161,475      
Direct Value   $2,427,922    

Indirect Value

   $4,299,408      
Total Shares   3,384,944      
Total Value   $6,727,329      


Paratek Pharmaceuticals Inc $79,642 Illumina Inc $1,609,480 Geron Corporation $478,300 Castle Biosciences Inc $0 Nuvation Bio Ord Shs Class A $260,500 Paratek Pharmaceuticals Inc $79,642 Illumina Inc $1,609,480 Geron Corporation $478,300 Castle Biosciences Inc $0 Nuvation Bio Ord Shs Class A $260,500
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Amylin Pharmaceuticals Inc AMLN President & Chief Exec... 2012-08-08 0 2012-08-08 0    Premium*  
            Paratek Pharmaceuticals Inc PRTK Director 2006-05-09 35,714 0    Premium*  
            Illumina Inc ILMN Director 2017-05-25 15,324 2008-05-16 0    Premium*  
            Corcept Therapeutics Inc CORT Director 2012-11-21 0 2019-02-07 130,575    Premium*  
            Geron Corporation GERN Director 2014-05-09 142,776 2019-03-29 51,323    Premium*  
            Equillium Inc EQ Chief Executive Office... 2018-10-16 0 2018-10-16 2,969,596    Premium*  
            Castle Biosciences Inc CSTL Director 2024-05-06 4,655 2024-05-06 9,981    Premium*  
            Nuvation Bio Ord Shs Class A NUVB Director 2021-02-10 25,000 2021-02-10 0    Premium*  
* Premium Members only  

Records found :    423         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 16 of 17
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
AMLN Amylin Pharmaceuticals In... President & Chief Executive Of   •       •      –    2008-04-21 4 GD $0.00 $0 I/I 177 44,402 0 -
AMLN Amylin Pharmaceuticals In... President & Chief Executive Of   •       •      –    2008-06-17 5 GD $0.00 $0 I/I 2,240 42,162 0 -
AMLN Amylin Pharmaceuticals In... President & Chief Executive Of   •       •      –    2008-08-11 5 GD $0.00 $0 I/I 150 42,012 0 -
AMLN Amylin Pharmaceuticals In... President & Chief Executive Of   •       •      –    2009-02-03 4 A $11.80 $6,903 D/D 585 13,197 0 -
AMLN Amylin Pharmaceuticals In... President & Chief Executive Of   •       •      –    2009-03-04 4 A $0.00 $0 I/I 2,550 3,455 0 -
AMLN Amylin Pharmaceuticals In... President & Chief Executive Of   •       •      –    2009-03-13 5 GA $0.00 $0 I/I 5,597 13,157 0 -
AMLN Amylin Pharmaceuticals In... President & Chief Executive Of   •       •      –    2009-03-13 5 GD $0.00 $0 I/I 5,597 35,118 0 -
AMLN Amylin Pharmaceuticals In... President & Chief Executive Of   •       •      –    2010-02-03 4 A $0.00 $0 I/I 1,360 4,815 0 -
AMLN Amylin Pharmaceuticals In... President & Chief Executive Of   •       •      –    2010-02-03 4 A $17.83 $7,346 D/D 412 16,524 0 -
AMLN Amylin Pharmaceuticals In... President & Chief Executive Of   •       •      –    2010-02-18 4 D $17.82 $625,803 I/I (35,118) 44,573 0 -
AMLN Amylin Pharmaceuticals In... President & Chief Executive Of   •       •      –    2010-02-18 4 OE $14.28 $636,547 I/I 44,573 79,691 0 -
AMLN Amylin Pharmaceuticals In... President & Chief Executive Of   •       •      –    2010-02-18 4 D $17.82 $54,048 D/D (3,033) 16,524 0 -
AMLN Amylin Pharmaceuticals In... President & Chief Executive Of   •       •      –    2010-02-18 4 OE $14.28 $43,314 D/D 3,033 19,557 0 -
AMLN Amylin Pharmaceuticals In... President & Chief Executive Of   •       •      –    2010-02-26 5 GD $0.00 $0 I/I 3,028 46,545 0 -
AMLN Amylin Pharmaceuticals In... President & Chief Executive Of   •       •      –    2010-02-26 5 GA $0.00 $0 I/I 3,028 16,185 0 -
AMLN Amylin Pharmaceuticals In... President & Chief Executive Of   •       •      –    2010-03-25 4 OE $9.63 $48,125 I/I 5,000 49,573 0 -
AMLN Amylin Pharmaceuticals In... President & Chief Executive Of   •       •      –    2010-11-22 4 OE $11.13 $278,125 I/I 25,000 74,573 0 -
AMLN Amylin Pharmaceuticals In... President & Chief Executive Of   •       •      –    2011-02-07 5 GA $16.26 $52,032 I/I 3,200 19,385 0 -
AMLN Amylin Pharmaceuticals In... President & Chief Executive Of   •       •      –    2011-02-07 5 GD $16.26 $52,032 I/I 3,200 37,821 0 -
AMLN Amylin Pharmaceuticals In... President & Chief Executive Of   •       •      –    2011-03-01 4 A $0.00 $0 D/D 25,000 32,178 0 -
AMLN Amylin Pharmaceuticals In... President & Chief Executive Of   •       •      –    2011-03-01 4 A $0.00 $0 I/I 1,630 6,445 0 -
AMLN Amylin Pharmaceuticals In... President & Chief Executive Of   •       •      –    2011-10-04 4 D $8.75 $253,566 I/I (28,979) 40,275 0 -
AMLN Amylin Pharmaceuticals In... President & Chief Executive Of   •       •      –    2011-10-04 4 OE $5.73 $257,850 I/I 45,000 41,021 0 -
AMLN Amylin Pharmaceuticals In... President & Chief Executive Of   •       •      –    2012-01-10 4 A $0.00 $0 D/D 30,000 62,178 0 -
AMLN Amylin Pharmaceuticals In... President & Chief Executive Of   •       •      –    2012-01-18 4 GD $11.46 $52,005 I/I 4,538 36,483 0 -
  423  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16  17      
  Page 16 of 17  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us